Neuroendocrine Prostate Tumor: A Case Report and Literature Review

Neuroendocrine Prostate Tumor: A Case Report and Literature Review - Neuroendocrine prostate cancer is a rare entity with a poor prognosis. It can present in a pure form (small or large cell neuroendocrine carcinoma) or mixed, that is to say associated with an adenocarcinomatous contingent. Rarely diagnosed de novo, primary large cell tumors are exceptional. The development of molecular analysis tools has provided important elements for understanding the origin of this histological subtype and the signaling pathways involved. This could also help to identify diagnostic and prognostic biomarkers as well as potential molecular targets. We report here the case of a 63-year-old patient diagnosed with mixed prostate cancer with large cell neuroendocrine component at a localized stage and detail the particularities of his management. Keywords: Prostate Cancer, Neuroendocrine Tumor, Adenocarcinoma, PSA, Hormone Therapy, Surgery.

Authors

Publication Details

Journal
African Journal of Medicine and Pharma Research
Published
2025-02-15
DOI
https://doi.org/10.18231/j.ajmpr.2024.002
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neuroendocrine Prostate Tumor: A Case Report and Literature Review

Zineb Benbrahim, Karima Oualla, Nawfel Mellas, Lamiae Amaadour et al.
African Journal of Medicine and Pharma Research
Prostate Cancer Treatment and Research
article

Neuroendocrine Prostate Tumor: A Case Report and Literature Review

Zineb Benbrahim, Karima Oualla, Nawfel Mellas, Lamiae Amaadour, Medyouni Hajar, Ouafki Imane, Chouef Jihane, Siyouri Oumaima, Mhirech Samia, Samia Arifi, Elhakym Samia
article en

Abstract

Neuroendocrine Prostate Tumor: A Case Report and Literature Review - Neuroendocrine prostate cancer is a rare entity with a poor prognosis. It can present in a pure form (small or large cell neuroendocrine carcinoma) or mixed, that is to say associated with an adenocarcinomatous contingent. Rarely diagnosed de novo, primary large cell tumors are exceptional. The development of molecular analysis tools has provided important elements for understanding the origin of this histological subtype and the signaling pathways involved. This could also help to identify diagnostic and prognostic biomarkers as well as potential molecular targets. We report here the case of a 63-year-old patient diagnosed with mixed prostate cancer with large cell neuroendocrine component at a localized stage and detail the particularities of his management. Keywords: Prostate Cancer, Neuroendocrine Tumor, Adenocarcinoma, PSA, Hormone Therapy, Surgery.

African Journal of Medicine and Pharma ResearchVol. 2(1)
Good health and well-being
Openalex Percentile: Top 95%
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Neuroendocrine Prostate Tumor: A Case Report and Literature Review — Zineb Benbrahim, Karima Oualla, et al. · African Journal of Medicine and Pharma Research (2025) | TGRS Research Map | TGRS